ClinicalTrials.gg
CompletedNCT05582356Updated May 22, 2024

Effect of Preoperative Oral Carbohydrate Loading on Elderly Patient Quality of Recovery in Total Knee Arthroplasty

An interventional study of Carbohydrate group (Group OC) and Placebo group (Group OP in Quality Of Recovery, sponsored by Karaman Training and Research Hospital. Completed at 1 site in Turkey (Türkiye). Open to participants aged 65 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-22.

Sponsored by Karaman Training and Research Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

This prospective randomized controlled study will be aimed to evaluate the effect of preoperative oral carbohydrate loading on the elderly patient's quality of recovery and satisfaction in undergoing knee arthroplasty (TKA) surgery with spinal anesthesia.

Read the detailed description

As an essential aspect of enhanced recovery after surgery, the advantages of preoperative oral carbohydrate loading (eg, improving patients' comfort during preoperative preparation, reducing nausea and vomiting, and reducing insulin resistance) have been shown by a large number of studies.

This study will be conducted as a single-center, prospective, randomized, double-blinded trial in a university hospital. Elderly ( > 65) patients scheduled for elective TKA will be screened for enrollment in the study. Patients will be randomized into an oral carbohydrate group (Group OC), and an oral placebo group (Group OP). Solid food will be forbidden starting at 20:00, and drinking will be banned after 22:00 the day before surgery. Oral carbohydrate preload will be administered to the Group OC. In Group OP, the blinded researcher will give an equal volume of placebo fluid orally at 22:00 and 2 hours before the operation in the ward. The participant will record that the liquid has been completely consumed

02

Conditions studied

  • Quality Of Recovery

Keywords

  • Oral Carbohydrate
  • Elderly Patient
  • Mini Mental State Examination
03

In context

Lead sponsor

Karaman Training and Research Hospital is the lead sponsor of 33 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physical status according to the American Society of Anesthesiologists (ASA) I-III
  • Patients scheduled for total knee arthroplasty

Exclusion criteria

Exclusion Criteria:

  • Previous operation on same knee
  • Hepatic or renal insufficiency
  • Younger than 65 years old
  • Patients undergoing general anesthesia
  • Allergy or intolerance to one of the study medications
  • ASA IV
  • Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
  • Chronic opioid use (taking opioids for longer than 3 months, or daily oral morphine equivalent of >5mg/day for one month)
  • impaired gastrointestinal motility
  • Fasting glucose >200
  • Acquired immunodeficiency
  • Severe malnutrition
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Carbohydrate group (Group OC)

    Preoperative education will be provided by researchers to the patients on the ward before fluid intake. Solid food will be forbidden starting at 20:00 p.m, and drinking will be forbidden after 22:00 p.m the day before surgery. Group OC will consume carbohydrate fluid at 22.00 p.m. and two hours before the surgery

    Dietary Supplement: Carbohydrate group (Group OC)

  • Sham comparator
    Placebo group (Group OP)

    Preoperative education will be provided by researchers to the patients on the ward before fluid intake. Solid food will be forbidden starting at 20:00 p.m, and drinking will be forbidden after 22:00 p.m the day before surgery. Group OP will consume an equal amount of water 22:00 p.m. and two hours before the surgery.

    Dietary Supplement: Placebo group (Group OP

Interventions

06

What researchers measure

Primary outcomes

  1. Quality of Recovery-15 score

    Minimum value: 0, Maximum value: 150, higher scores mean better.

    Time frame: Postoperative 24th hour

Secondary outcomes

  1. Quality of Recovery-15 score

    Minimum value: 0, Maximum value: 150, higher scores mean better.

    Time frame: preoperative, postoperative day 7

  2. Numerical Rating Scale

    Range 0-10, 0=no pain, 10=the worse pain ever.

    Time frame: 24 hours

  3. Opioid consumption

    Opioid consumption

    Time frame: 24 hours

  4. Range of knee motion

    Range of knee motion

    Time frame: 48 hours

  5. Patient mobilization

    Patient reporting time of first standing to the side of the bed and time up and go test 2 days

    Time frame: 48 hours

  6. Patient well-being (thirst, hunger, mouth dryness, nausea and vomiting, fatigue) will be assessed just before the operating room admission

    5: very satisfied, 4: somewhat satisfied, 3: neutral, 2: somewhat dissatisfied, 1: very dissatisfied

    Time frame: preoperative

  7. Mini Mental State Examination

    Mini Mental State Examination Scale (This scale is a 30-point questionnaire that is used extensively in clinical and research settings to measure cognitive impairment. Any score of 24 or more (out of 30) indicates a normal cognition. Below this, scores can indicate severe (≤9 points), moderate (10-18 points) or mild (19-23 points) cognitive impairment.)

    Time frame: preoperative and postoperatve day 1

  8. Sleep Quality measured with Likert Scale

    Patients' perceived sleep quality will be assessed with a Likert scale. Likert scale is scored from Likert scale where 1 = very dissatisfied, 2 = dissatisfied, 3 = neutral, 4 = satisfied and 5 = very satisfied

    Time frame: One week after surgery

  9. Glucose measurement

    Glucose measurement

    Time frame: Postoperative 24th hour

07

Study locations

1 site
  • Karaman Training and Research Hospital
    Karaman, 70200, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2023 to primary completion in Mar 2024, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2022
First posted
Oct 17, 2022
StartActual
Oct 20, 2023
Primary completionActual
Mar 4, 2024
CompletionActual
Mar 18, 2024
Last update
May 22, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05582356
Lead sponsor
Karaman Training and Research Hospital
Responsible party
Sponsor
First posted
Oct 17, 2022
Start date
Oct 20, 2023
Primary completion
Mar 4, 2024
Completion
Mar 18, 2024
Last update
May 22, 2024

Study contacts

Betül Başaran, MD,DESA
study director · Karaman Training and Research Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Carbohydrates

Start the discussion